drugset / Trial / NCT01601834

A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340

NCT01601834

Phase 1 Completed 20 enrolled Pfizer
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study in healthy people is to evaluate safety, toleration and time course of plasma concentration of single oral doses of PF-06273340. The effect of food on the Pharmacokinetic of PF-06273340 may also be investigated.

Timeline

Start
2012-05
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06273340 Small molecule Oral

Indications

No indication recorded.